Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Bill Wexler's Dog Pound -- Ignore unavailable to you. Want to Upgrade?

To: Kevin Podsiadlik who wrote (4175)	10/5/1999 6:19:00 PM
From: DanZ	Read Replies (1) \| Respond to of 10293

It makes no difference why they aren't calling it a cure for the common cold. The fact remains as I stated: GumTech does not characterize Zicam as a cure for the common cold. I don't know what Brown meant by regulatory reasons. It could be that they have to wait for the second round of clinical studies to be completed before they can say that, or it could be that "cure" has a legal connotation that must be proven with a different type of clinical study than they are doing. <And you still don't understand about averaging in, do you?> Of course I do. I have been averaging into GUMM since my first trade in late January. Do you really think that I bought my entire position in a single trade? You just didn't interpret my comment correctly. Buy as much as you can afford doesn't mean buy it all at once and it has different meanings to different people depending on their risk aversion.